Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German law changes will upgrade surveillance & "seal the cracks"

This article was originally published in Clinica

Executive Summary

Changes to Germany's medical product law, the Medizinproduktegesetz (MPG) coming up in January 2002 will "seal any cracks in the existing regulations". That is the confident view of Hans Georg Will, director of the medical devices department at the ministry of health. Speaking at a special MPG transposition conference last week held by the medical device industry association (BVMed), he said the new law - the second amendment of the MPG - was better targeted and clearer than existing legislation. It will also transpose the two most recent European directives on in vitro diagnostics (IVDs) and medical devices, which incorporated derivatives from human blood or plasma.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT074019

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel